APPECO

APPECO integrates evidence from randomized clinical trials to support decision-making in rehabilitation for patients with Multiple Sclerosis (MS).

Key Features:

• Comprehensive Database: APPECO hosts curated data from 250 randomized clinical trials covering 293 interventions, 1,250 effect sizes, and 53 patient outcomes.
• Focus on MS Symptoms: Initially developed as a proof-of-concept for fatigue and cognitive function, APPECO also includes intervention studies for depression, pain, and mobility.
• Quality Assessment: The resource highlights availability of low risk-of-bias studies for fatigue, cognitive function, and depression, and reports a relative scarcity of such studies for pain and mobility.
• Knowledge Translation: APPECO consolidates up-to-date randomized trial evidence to inform selection of rehabilitation interventions in MS.
• Sustainability and Updates: The database is maintained with periodic updates approximately every 2–6 months based on new randomized controlled trials.

Scientific Applications:

• Evidence synthesis for researchers: Provides a consolidated RCT evidence base to evaluate the effectiveness of rehabilitation interventions in MS.
• Clinical decision support: Informs clinicians about comparative intervention effects on MS outcomes such as fatigue, cognition, depression, pain, and mobility.
• Policy and guideline development: Summarizes randomized trial evidence to support evidence-based policy and guideline formulation for MS rehabilitation.
• Research prioritization: Identifies gaps in high-quality randomized evidence to guide future MS rehabilitation research priorities.

Methodology:

Rigorous curation and synthesis of randomized clinical trials using systematic reviews and incorporation of risk-of-bias assessment to evaluate study quality.